Nattokinase Discontinuation Before Colonoscopy
You should stop taking nattokinase at least 3 days before your colonoscopy to minimize bleeding risk, similar to direct oral anticoagulants (DOACs). 1
Understanding Nattokinase and Bleeding Risk
Nattokinase is a serine protease derived from natto (a traditional Japanese fermented soybean food) with significant fibrinolytic and antithrombotic properties 2. Although not classified as a prescription anticoagulant, nattokinase has blood-thinning effects that can increase bleeding risk during invasive procedures like colonoscopy.
Pharmacokinetics of Nattokinase
- Peak serum levels occur approximately 13.3 ± 2.5 hours after ingestion 2
- Detectable in blood for up to 24 hours after a single dose 2
Recommended Management
Based on the British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines for anticoagulants with similar properties:
For Colonoscopy Without Polypectomy (Low-Risk Procedure)
- Stop nattokinase the morning of the procedure 1
For Colonoscopy With Possible Polypectomy (High-Risk Procedure)
- Stop nattokinase 3 days before the procedure 1
- This timing aligns with recommendations for DOACs, which have similar anticoagulant effects
Resuming Nattokinase After Colonoscopy
- Resume nattokinase 2-3 days after the procedure, particularly if polypectomy was performed 1
- This allows adequate time for healing at any biopsy or polypectomy sites
Important Considerations
Risk of Post-Polypectomy Bleeding
- Colonoscopy with polypectomy is classified as a high-risk procedure for bleeding 1
- Most post-colonoscopy bleeding complications occur within 14 days, with 96% occurring within the first two weeks 3
Communicating with Your Healthcare Provider
- Inform your gastroenterologist about your nattokinase use before the procedure
- Follow the bowel preparation instructions carefully, as this is separate from anticoagulation management 1
Special Circumstances
If you're taking nattokinase for a specific medical condition, consult with the prescribing healthcare provider about:
- The safety of temporarily discontinuing nattokinase
- Whether any alternative measures should be taken during the discontinuation period
This approach balances the need to minimize bleeding risk during colonoscopy while ensuring your safety throughout the perioperative period.